Hormones Secretion and Rho GTPases in Neuroendocrine Tumors

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Neuroendocrine tumors (NETs) are a diverse group of neoplasms originating from hormone-secreting cells.
• NETs frequently exhibit dysregulated secretory activity, impacting hormone production and release.
• Neuroendocrine secretion is a calcium-dependent exocytosis process, intricately regulated by Rho GTPases.

Purpose of the Study:

• To review and synthesize current knowledge on mutations and expression level alterations of Rho GTPases and their regulators in NETs.
• To elucidate the potential mechanisms by which these alterations impact neuroendocrine secretion in NETs.

Main Methods:

• Comprehensive literature review of studies identifying mutations and expression changes in Rho GTPases and their regulators (Rho guanine nucleotide-exchange factors and Rho GTPase-activating proteins) in NETs.
• Analysis of the functional consequences of these genetic and expression alterations on neuroendocrine secretion pathways.

Main Results:

• Numerous mutations and altered expression levels of Rho GTPases and their regulators have been identified in various NETs.
• These molecular changes are implicated in the dysregulation of calcium-regulated exocytosis, a key process in neuroendocrine secretion.

Conclusions:

• Rho GTPases and their regulatory proteins are critical players in the pathogenesis of NETs.
• Understanding these molecular alterations offers potential therapeutic targets for managing NETs and their secretory dysfunctions.